Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.

Advanced DNA sequencing technologies and a new stem cell research model have allowed an international team of scientists to ...

Abbott Laboratories is set to report Q3 earnings, with EPS expectations of $1.30, reflecting 8.3% YoY growth. Learn more ...

The removal of a diseased parathyroid gland could reduce the risk of people developing diabetes by 30%, according to new ...

Nearly half of adults worldwide who are living with diabetes don’t even know they have it, leaving millions vulnerable to dangerous complications. A sweeping new study, published in the journal The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has approved an expanded indication for the ...

People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...

Eating a Mediterranean diet — including lots of produce, whole grains and healthy fats — while also adding a few healthy lifestyle behaviors, could lower your diabetes risk by almost a third. That's ...

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing real-time readings and alerts for diabetics. This innovative device aims to ...

An AI-powered system helped people with type 2 diabetes lower HbA1c and reduce the need for glucose-lowering medications. The system provided personalized lifestyle recommendations and took into ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...